Arbutus Biopharma Corp insider trading

Does following Arbutus Biopharma Corp’s insiders pay?

From August 17, 2017 to August 16, 2024, 2 insiders reported 0 open-market purchases and 3 sales not made under a pre-set plan in Arbutus Biopharma Corp. After sales, the shares moved −87.6% against the index over 12 months (a negative figure means selling was the right call).

Moves are the shares’ return including dividends minus the S&P 500’s, from the close on the first trading day after each report; the number of trades with a finished 12-month window is in brackets. Green means the trade went the insider’s way (a purchase ahead of the index, a sale followed by the shares trailing it). A trade reported both by a director or officer and by a fund or company they are linked to counts once here, under the person. Purchases count only where the share price actually traded was at least $5. These figures describe what the shares did, not why anyone traded. Insiders across all companies.